Show Us The Birth Certificate? An Authorless US FDA Import Policy

For two decades it has been almost dogma in the US pharmaceutical industry that no FDA commissioner would sign off on a policy to permit wholesale imports of drugs from Canada. Now that a proposed rule has been issued – it still may be true.

USA Passport with Social Security Card, Drivers License and Birth Certificate.

The 18 December proposed rule issued by the US Food & Drug Administration to set up a process to permit wholesale importation of drugs from Canada is a landmark event in that agency’s history.

More from Pricing Debate

More from Market Access

PBMs No Longer Profit From Rebates But Plans Benefit; Should Sponsors Push More For Reform?

 
• By 

Employers and other health plan sponsors may need to push for better targeted reforms that lower cost sharing for patients.

Canada’s HTA Agency Reveals How To Submit AI-Driven Evidence

 

Recognizing that the evidence it receives in applications for health technology assessments will increasingly be informed by artificial intelligence, the CDA-AMC has clarified its expectations for companies that use AI methods in the generation and/or reporting of evidence.

Why Successful Companies Are ‘Tough On Themselves’ When It Comes To HTA

 

Pharmaceutical companies need to “pressure test” their clinical development strategies early for health technology assessment purposes, particularly in light of the new EU HTA Regulation, a life sciences consultant says.